XP-005 Personalized Vaccine Alone or in Combination With Toripalimab for the Prevention of Relapse After Remission in Acute Myeloid Leukemia
Clinical trial NCT06980155 · RECRUITING
Trial details
- NCT number
- NCT06980155
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-30
- Primary completion
- 2027-01-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.